ANNX 5.23 (+0.19%)
US03589W1027BiotechnologyBiotechnology

Annexon (ANNX) Stock Highlights

5.23 | +0.19%
2024-12-21 04:55:54
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Annexons product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; and ANX009, for systemic autoimmune diseases.

Statistics

Range Today
5.05 5.32
Volume Today 3.53M
Range 1 Year
2.77 8.4
Volume 1 Year 461.94M
Range 3 Year
1.57 13.67
Volume 3 Year 689.82M
Range 10 Year
1.57 38.01
Volume 10 Year 762.51M

Highlights

Market Capitalization 763.88M (small)
Floating Shares 68.84M
Current Price 5.23
Price To Earnings -6.12
Price To Book 2.11
Earnings Per Share -1.21
Payout Ratio 0%

Performance

Latest +0.19%
1 Month -4.21%
3 Months -25.07%
6 Months +3.77%
1 Year +86.12%
3 Years -59.86%
5 Years -69.94%
10 Years -69.94%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.